On Tuesday, Cardlytics Inc (NASDAQ: CDLX) was -4.16% drop from the session before settling in for the closing price of $4.09. A 52-week range for CDLX has been $2.89 – $20.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Communication Services sector company grew by 17.35% over the past five years. When this article was written, the company’s average yearly earnings per share was at -10.30%. With a float of $48.27 million, this company’s outstanding shares have now reached $50.34 million.
Let’s look at the performance matrix of the company that is accounted for 434 employees. In terms of profitability, gross margin is 44.23%, operating margin of -66.36%, and the pretax margin is -93.55%.
Cardlytics Inc (CDLX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cardlytics Inc stocks. The insider ownership of Cardlytics Inc is 5.02%, while institutional ownership is 61.05%. The most recent insider transaction that took place on Dec 03 ’24, was worth 3,447,453. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Financial Officer sold 25,118 for $3.43, making the entire transaction worth $86,155. This insider now owns 116,481 shares in total.
Cardlytics Inc (CDLX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.29 earnings per share (EPS) during the time that was less than consensus figure (set at 0.17) by -0.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.10% during the next five years compared to -5.75% drop over the previous five years of trading.
Cardlytics Inc (NASDAQ: CDLX) Trading Performance Indicators
You can see what Cardlytics Inc (CDLX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.11, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Cardlytics Inc (CDLX)
Cardlytics Inc (NASDAQ: CDLX) saw its 5-day average volume 0.74 million, a negative change from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 75.40%. Additionally, its Average True Range was 0.31.
During the past 100 days, Cardlytics Inc’s (CDLX) raw stochastic average was set at 15.63%, which indicates a significant decrease from 59.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.38% in the past 14 days, which was lower than the 161.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.79, while its 200-day Moving Average is $7.49. Nevertheless, the first resistance level for the watch stands at $4.05 in the near term. At $4.18, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.27. If the price goes on to break the first support level at $3.83, it is likely to go to the next support level at $3.74. Assuming the price breaks the second support level, the third support level stands at $3.61.
Cardlytics Inc (NASDAQ: CDLX) Key Stats
There are 50,822K outstanding shares of the company, which has a market capitalization of 199.22 million. As of now, sales total 309,200 K while income totals -134,700 K. Its latest quarter income was 67,060 K while its last quarter net income were -145,180 K.